H.R. 5435 · 117th Congress
BRAIN Act of 2021
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
BlumenauerSponsor6 cosponsors · 4 D, 2 R
2 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Bringing Regulatory Advances Into Neuroscience Act of 2021 or the BRAIN Act of 2021
What it does: CRS summary · Introduced in House · Sep 30, 2021
Bringing Regulatory Advances Into Neuroscience Act of 2021 or the BRAIN Act of 2021
This bill requires the Food and Drug Administration (FDA) to establish the Neuroscience Center of Excellence.
The center must develop and implement processes to coordinate FDA activities related to a major disease area or areas affecting the brain or central nervous system.
The FDA must also establish and maintain the Neuroscience Translation Working Group to advise the center. If the FDA terminates the center, the working group shall advise the FDA.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: BRAIN Act of 2021
Also known as: Bringing Regulatory Advances Into Neuroscience Act of 2021
Latest action (Oct 1, 2021): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Sep 30, 2021
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.